BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $6.911B (100.0% shares, 0.0% debt)

Holdings (5)

SGRY SURGERY PARTNERS INC 39.1%

Value $2.701B Shares 49,064,576 Est. Cost $32.73 Unrealized +51.1%

— CEREVEL THERAPEUTICS HLDNG I 30.7%

Value $2.123B Shares 60,632,356 Est. Cost $16.58 Unrealized —

— DIVERSEY HLDGS LTD 25.9%

Value $1.791B Shares 236,561,159 Est. Cost $14.71 Unrealized —

AVAH AVEANNA HEALTHCARE HLDGS INC 4.0%

Value $278M Shares 81,600,880 Est. Cost $11.86 Unrealized -54.2%

ADV ADVANTAGE SOLUTIONS INC 0.3%

Value $18.44M Shares 2,890,000 Est. Cost $10.52 Unrealized -34.2%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
SGRY	SURGERY PARTNERS INC	49,064,576	$2.701B	39.1%	$32.73	+51.1%	COM	86881A100
—	CEREVEL THERAPEUTICS HLDNG I	60,632,356	$2.123B	30.7%	$16.58	—	COM	15678U128
—	DIVERSEY HLDGS LTD	236,561,159	$1.791B	25.9%	$14.71	—	ORD SHS	G28923103
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$278M	4.0%	$11.86	-54.2%	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$18.44M	0.3%	$10.52	-34.2%	COM CL A	00791N102